Literature DB >> 16446408

On the difficulty of neurosurgical end of life decisions.

C Schaller1, M Kessler.   

Abstract

OBJECTIVE: To analyse the process of end of life decisions in a neurosurgical environment.
METHODS: All 113 neurosurgical patients, who were subject to so called end of life decisions within a one year period were prospectively enrolled in a computerised data bank. Decision pathways according to patient and physician related parameters were assessed.
RESULTS: Leading primary diagnoses of the patients were traumatic brain injury and intracranial haemorrhage. Forty-five patients had undergone an emergency neurosurgical operation prior to end of life decision, N = 69 were conservatively treated, which included intracranial pressure recording, or they were not offered neurosurgical care because of futile prognosis. N = 111 died after a median of two (zero to nine) days. Two, in whom the end of life decisions were revised, survived. Clear decisions to terminate further treatment were made by a senior staff member on call being informed by the senior resident on call (27.4%), difficult decisions on the basis of extensive round discussions (71.7%), and very difficult decision by an interdisciplinary ethical consult (0.9%). Decisions were further substantiated by electrophysiological examinations in N = 59.
CONCLUSION: End of life decisions are to be considered standard situations for neurosurgeons. These decisions may reach a high rate of "positive" prediction, if substantiated by electrophysiological examinations as well as on the grounds of clinical experience and respect for the assumed will of the patient. The fact that patients may survive following revision of an end of life decision underlines the necessity for repeated reassessment of these decisions. Ethical training for neurosurgeons is to be encouraged.

Entities:  

Mesh:

Year:  2006        PMID: 16446408      PMCID: PMC2563335          DOI: 10.1136/jme.2005.011767

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  15 in total

Review 1.  End-of-life care in the intensive care unit: can we do better?

Authors:  M M Levy
Journal:  Crit Care Med       Date:  2001-02       Impact factor: 7.598

Review 2.  Cultural differences in end-of-life care.

Authors:  J L Vincent
Journal:  Crit Care Med       Date:  2001-02       Impact factor: 7.598

3.  Cardiopulmonary resuscitation performed in patients with terminal illness in Chiang Mai University Hospital, Thailand.

Authors:  S Sittisombut; E J Love; C Sitthi-Amorn
Journal:  Int J Epidemiol       Date:  2001-08       Impact factor: 7.196

4.  Crisis in resources: a neurosurgical prospective.

Authors:  K Ashkan; R J Edwards; B A Bell
Journal:  Br J Neurosurg       Date:  2001-08       Impact factor: 1.596

5.  Withdrawal of life support: intensive caring at the end of life.

Authors:  Thomas J Prendergast; Kathleen A Puntillo
Journal:  JAMA       Date:  2002-12-04       Impact factor: 56.272

6.  Vietnam, 1968-1969: a place and a year like no other.

Authors:  Patrick J Kelly
Journal:  Neurosurgery       Date:  2003-04       Impact factor: 4.654

7.  Decisions to limit treatment in a neurosurgical unit: an aspect of audit of mortality.

Authors:  P Barlow; B Jennett
Journal:  Scott Med J       Date:  1991-08       Impact factor: 0.729

8.  Factors associated with withdrawal of mechanical ventilation in a neurology/neurosurgery intensive care unit.

Authors:  M N Diringer; D F Edwards; V Aiyagari; H Hollingsworth
Journal:  Crit Care Med       Date:  2001-09       Impact factor: 7.598

9.  Family involvement in end-of-life hospital care.

Authors:  Jeanne M Tschann; Sharon R Kaufman; Guy P Micco
Journal:  J Am Geriatr Soc       Date:  2003-06       Impact factor: 5.562

10.  The prognostic value of somatosensory evoked potentials in traumatic primary and secondary brain stem lesions.

Authors:  P Christophis
Journal:  Zentralbl Neurochir       Date:  2004
View more
  6 in total

1.  Differences in end-of-life care in the ICU across patients cared for by medicine, surgery, neurology, and neurosurgery physicians.

Authors:  Erin K Kross; Ruth A Engelberg; Lois Downey; Joseph Cuschieri; Matthew R Hallman; W T Longstreth; David L Tirschwell; J Randall Curtis
Journal:  Chest       Date:  2014-02       Impact factor: 9.410

2.  Neurosurgical patients admitted via the emergency department initiating comfort care measures: a prospective cohort analysis.

Authors:  Joseph R Linzey; Rachel Foshee; Sudharsan Srinivasan; Arjun R Adapa; Meghan L Wind; Carina Brake; Badih Junior Daou; Kyle Sheehan; Thomas C Schermerhorn; Teresa L Jacobs; Aditya S Pandey
Journal:  Acta Neurochir (Wien)       Date:  2020-08-21       Impact factor: 2.216

3.  Reasons, considerations, difficulties and documentation of end-of-life decisions in European intensive care units: the ETHICUS Study.

Authors:  Charles L Sprung; Thomas Woodcock; Peter Sjokvist; Bara Ricou; Hans-Henrik Bulow; Anne Lippert; Paulo Maia; Simon Cohen; Mario Baras; Seppo Hovilehto; Didier Ledoux; Dermot Phelan; Elisabet Wennberg; Wolfgang Schobersberger
Journal:  Intensive Care Med       Date:  2007-11-09       Impact factor: 17.440

4.  Surgical decision making for the elderly patients in severe head injuries.

Authors:  Kyeong-Seok Lee; Jae-Jun Shim; Seok-Man Yoon; Jae-Sang Oh; Hack-Gun Bae; Jae-Won Doh
Journal:  J Korean Neurosurg Soc       Date:  2014-04-30

5.  Treatment-limiting decisions in patients with severe traumatic brain injury in a Norwegian regional trauma center.

Authors:  Annette Robertsen; Reidun Førde; Nils Oddvar Skaga; Eirik Helseth
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-04-26       Impact factor: 2.953

6.  Randomized Evaluation of Surgery in Elderly with Traumatic Acute SubDural Hematoma (RESET-ASDH trial): study protocol for a pragmatic randomized controlled trial with multicenter parallel group design.

Authors:  Jeroen T J M van Dijck; Thomas A van Essen; Ranjit D Singh; Hester F Lingsma; Suzanne S Polinder; Erwin J O Kompanje; Erik W van Zwet; Ewout W Steyerberg; Godard C W de Ruiter; Bart Depreitere; Wilco C Peul
Journal:  Trials       Date:  2022-03-29       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.